Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Oncopeptides | OND | Sep 20, 2024 | 0.17 | -0.57 |
Oncotherpapy Science Inc | 30O | Sep 20, 2024 | 0.23 | +13.86 |
OncoZenge | 8LY | Sep 20, 2024 | 0.57 | +2.14 |
ONDAS HLDGS INC. DL-,0001 | 1B8 | Sep 20, 2024 | 0.67 | -3.60 |
Onde S.A. | 0XF | Sep 20, 2024 | 2.58 | +6.19 |
Ondine Biomedical Inc | VF5 | Sep 20, 2024 | 0.04 | +19.72 |
ONE Gas, Inc. | OG9 | Sep 20, 2024 | 66.00 | +0.76 |
One Liberty Properties, Inc. | O1A | Sep 20, 2024 | 24.80 | -1.59 |
One Media iP Group Plc | 1M9 | Sep 20, 2024 | 0.03 | 0.00 |
One More Level S.A. | 1OJ | Sep 20, 2024 | 0.35 | -7.50 |
One Stop Systems, Inc. | 5MU | Sep 20, 2024 | 1.84 | -0.54 |
OneApex Limited | CWF | Sep 20, 2024 | 0.08 | +2.55 |
ONEFLOW AB | L58 | Sep 20, 2024 | 3.20 | -0.62 |
OneMain Holdings, Inc. | 0S1 | Sep 20, 2024 | 44.17 | +0.16 |
ONEOK, Inc. | ONK | Sep 20, 2024 | 83.62 | -1.08 |
OneSpan Inc. | VDY | Sep 20, 2024 | 14.40 | 0.00 |
OneSpaWorld Holdings Limited - | ORW | Sep 20, 2024 | 14.60 | 0.00 |
Onex Corp. | ONE | Sep 20, 2024 | 62.00 | +2.48 |
Ono Pharmaceutical Co. Ltd | ON4 | Sep 20, 2024 | 12.00 | -0.83 |
ONTEX GROUP NV EO -,01 | OT7 | Sep 20, 2024 | 8.78 | +1.04 |
Onto Innovation Inc. | NNM | Sep 20, 2024 | 181.00 | +7.10 |
Ontrak | HY10 | Sep 20, 2024 | 0.13 | -19.35 |
Ontrak, Inc. - 9.50% Series A Cumulative Perpetual Preferred | HY1 | Sep 20, 2024 | 0.17 | -0.59 |
Onward Medical NV | 63E | Sep 20, 2024 | 4.66 | -0.21 |
Onxeo | C4X | Sep 20, 2024 | 0.08 | +13.58 |
oOh media Limited | 0OH | Sep 20, 2024 | 0.75 | +2.04 |
OOIL | ORI1 | Sep 20, 2024 | 11.63 | +3.38 |
OP Bancorp | OP3 | Sep 20, 2024 | 11.30 | +2.73 |
OPAP (CR) | GF8 | Sep 20, 2024 | 16.19 | +3.06 |
Opawica Explorations Inc. | OE5 | Sep 20, 2024 | 0.06 | +1.61 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.